BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 30065045)

  • 1. Defining the role of glucocorticoids in inflammation.
    Ronchetti S; Migliorati G; Bruscoli S; Riccardi C
    Clin Sci (Lond); 2018 Jul; 132(14):1529-1543. PubMed ID: 30065045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucocorticoids and inflammation revisited: the state of the art. NIH clinical staff conference.
    Franchimont D; Kino T; Galon J; Meduri GU; Chrousos G
    Neuroimmunomodulation; 2002-2003; 10(5):247-60. PubMed ID: 12759562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insights.
    Coutinho AE; Chapman KE
    Mol Cell Endocrinol; 2011 Mar; 335(1):2-13. PubMed ID: 20398732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiinflammatory action of glucocorticoids--new mechanisms for old drugs.
    Rhen T; Cidlowski JA
    N Engl J Med; 2005 Oct; 353(16):1711-23. PubMed ID: 16236742
    [No Abstract]   [Full Text] [Related]  

  • 5. Therapeutic Mechanisms of Glucocorticoids.
    Vandewalle J; Luypaert A; De Bosscher K; Libert C
    Trends Endocrinol Metab; 2018 Jan; 29(1):42-54. PubMed ID: 29162310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The search for safer glucocorticoid receptor ligands.
    Rosen J; Miner JN
    Endocr Rev; 2005 May; 26(3):452-64. PubMed ID: 15814846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Significance of cytokines for bone loss--are there possible interventions?].
    Scharla SH
    Z Rheumatol; 2001 Apr; 60(2):104-6. PubMed ID: 11383043
    [No Abstract]   [Full Text] [Related]  

  • 8. Glucocorticoids.
    Spies CM; Strehl C; van der Goes MC; Bijlsma JW; Buttgereit F
    Best Pract Res Clin Rheumatol; 2011 Dec; 25(6):891-900. PubMed ID: 22265268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms involved in the side effects of glucocorticoids.
    Schäcke H; Döcke WD; Asadullah K
    Pharmacol Ther; 2002 Oct; 96(1):23-43. PubMed ID: 12441176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-inflammatory actions of glucocorticoids: molecular mechanisms.
    Barnes PJ
    Clin Sci (Lond); 1998 Jun; 94(6):557-72. PubMed ID: 9854452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The molecular complexity of glucocorticoid actions in inflammation - a four-ring circus.
    Goulding NJ
    Curr Opin Pharmacol; 2004 Dec; 4(6):629-36. PubMed ID: 15525555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular mechanisms of glucocorticoids in the control of inflammation and lymphocyte apoptosis.
    Tuckermann JP; Kleiman A; McPherson KG; Reichardt HM
    Crit Rev Clin Lab Sci; 2005; 42(1):71-104. PubMed ID: 15697171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An overview of the adverse reactions to adrenal corticosteroids.
    Frauman AG
    Adverse Drug React Toxicol Rev; 1996 Nov; 15(4):203-6. PubMed ID: 9113247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel glucocorticoids: where are we now and where do we want to go?
    Buttgereit F; Spies CM; Bijlsma JW
    Clin Exp Rheumatol; 2015; 33(4 Suppl 92):S29-33. PubMed ID: 26457359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimized glucocorticoid therapy: teaching old drugs new tricks.
    Strehl C; Buttgereit F
    Mol Cell Endocrinol; 2013 Nov; 380(1-2):32-40. PubMed ID: 23403055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting inflammation using selective glucocorticoid receptor modulators.
    De Bosscher K; Haegeman G; Elewaut D
    Curr Opin Pharmacol; 2010 Aug; 10(4):497-504. PubMed ID: 20493772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Glucocorticoids and their receptor: mechanisms of action and clinical implications].
    Roumestan C; Gougat C; Jaffuel D; Mathieu M
    Rev Med Interne; 2004 Sep; 25(9):636-47. PubMed ID: 15363619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New developments in glucocorticoid therapy: selective glucocorticoid receptor agonists, nitrosteroids and liposomal glucocorticoids].
    Huisman AM; Jacobs JW; Buttgereit F; Bijlsma JW
    Ned Tijdschr Geneeskd; 2006 Mar; 150(9):476-80. PubMed ID: 16553045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucocorticoids: do we know how they work?
    Saklatvala J
    Arthritis Res; 2002; 4(3):146-50. PubMed ID: 12010562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting the side effects of steroid therapy in autoimmune diseases: the role of GILZ.
    Fan H; Morand EF
    Discov Med; 2012 Feb; 13(69):123-33. PubMed ID: 22369971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.